Penumbra, Inc. (PEN) Reports Q2 EPS of $0.01, Raises FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Penumbra, Inc. Reports Second Quarter 2016 Financial Results
August 9, 2016 4:05 PM EDTALAMEDA, Calif., Aug. 9, 2016 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today reported financial results for the second quarter ended June 30, 2016.
Revenue of $65.1 million in the second quarter of 2016, an increase of 53.9%, or 53.2% in constant currency1, over the second quarter of 2015.Second Quarter 2016 Financial ResultsTotal revenue grew to $65.1 million for the second quarter of... More
